Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-12-16

Clinical Trial Update: Embecta AID System in Adults With Type 2 Diabetes [NA]

View source ↗

Summary

A clinical trial evaluating the Embecta AID System in adults with Type 2 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Embecta AID System

Snippet

Sponsor: Embecta Corp. | Conditions: Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM) | NA | Status: WITHDRAWN